Zacks Investment Research on MSN
EW wins FDA approval for SAPIEN M3 as first transseptal TMVR therapy
Edwards Lifesciences EW announced that the FDA approved its SAPIEN M3 transcatheter mitral valve replacement system, making ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results